中文名称 |
英文名称 |
CAS号 |
化学式 |
结构式图片 |
AZD9291中间体1 |
N1-(2-dimethylaminoethyl)-5-methoxy-N1-methyl-N4-[4-(1-methylindol-3-yl)pyrimidin-2-yl]benzene-1,2,4-triamine |
1421372-66-8 |
C25H31N7O |
|
AZD9291(甲磺酸盐) |
osimertinib mesylate |
1421373-66-1 |
CH4O3S*C28H33N7O2 |
|
AZD5363消旋产品 |
Capivasertib |
1143532-47-1 |
C21H25ClN6O2 |
|
AZD3759盐酸盐 |
4-[(3-chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl (2R)-2,4-dimethylpiperazine-1-carboxylate hydrochloride |
1626387-81-2 |
C22H23ClFN5O3*ClH |
|
AZD3514抑制剂 |
1-(4-(2-(4-(1-(3-(trifluoromethyl)-7,8-dihydro-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl)phenoxy)ethyl)piperazin-1-yl)ethanone |
1240299-33-5 |
C25H32F3N7O2 |
|
AZD2014; 3-[2,4-双((3S)-3-甲基吗啉-4-基)吡啶并[5,6-e]嘧啶-7-基]-N-甲基苯甲酰胺 |
AZD2014 |
1009298-59-2 |
C25H30N6O3 |
|
AZD 7687; [反式-4-[4-(6-氨基甲酰基-3,5-二甲基吡嗪-2-基)苯基]环己基]乙酸 |
{trans-4-[4-(6-carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid |
1166827-44-6 |
C21H25N3O3 |
|
AXL和C-MET抑制剂(CEP-40783) |
N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]-3-fluorophenyl]-3-(4-fluorophenyl)-1,2,3,4-tetrahydro-1-(1-methylethyl)-2,4-dioxo-5-pyrimidinecarboxamide |
1437321-24-8 |
C31H26F2N4O6 |
|
AVL-292 中间体 |
N<sup>4</sup>-(3-aminophenyl)-5-fluoro-N<sup>2</sup>-(4-(2-methoxyethoxy)phenyl)pyrimidine-2,4-diamine |
1202759-91-8 |
C19H20FN5O2 |
|
AURORA-A激酶抑制剂(MK-5108) |
MK-5108 |
1010085-13-8 |
C22H21ClFN3O3S |
|
ATRP 羟基引发剂 |
2-hydroxyethyl 2-bromoisobutyrate |
189324-13-8 |
C6H11BrO3 |
|
ATM激酶抑制剂(CP-466722) |
1-(6,7-dimethoxyquinazolin-4-yl)-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine |
1080622-86-1 |
C17H15N7O2 |
|
ASP 3026; N2-[2-甲氧基-4-[4-(4-甲基-1-哌嗪基)-1-哌啶基]苯基]-N4-[2-[(1-甲基乙基)磺酰基]苯基]-1,3,5-三嗪-2,4-二胺 |
ASP3026 |
1097917-15-1 |
C29H40N8O3S |
|
ARQ092盐酸盐 |
3-(3-(4-(1-aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine hydrochloride |
1313883-00-9 |
C27H24N6*ClH |
|
ARN-509杂质 |
N-desmethylapalutamide |
1332391-11-3 |
C20H13F4N5O2S |
|
AR-R17779盐酸盐 |
Ar-r 17779 hydrochloride |
178419-42-6 |
C9H15ClN2O2 |
|
AP26113中间体 |
(2-((2,5-dichloropyrimidin-4-yl)amino)phenyl)dimethylphosphine oxide |
1197953-49-3 |
C12H12Cl2N3OP |
|
AMG-221; (5S)-2-[(1S,2S,4R)-双环[2.2.1]庚烷-2-氨基]-5-甲基-5-异丙基-4(5H)-噻唑酮 |
AMG 221 |
1095565-81-3 |
C14H22N2OS |
|
ALPHA-载脂蛋白-土霉素 |
α-apo-oxytetracycline |
18695-01-7 |
C22H22N2O8 |
|
ALPHA-芋螺毒素IM-I |
Gly-Cys-Cys-Ser-Asp-Pro-Arg-Cys-Ala-Trp-Arg-Cys-NH2 |
156467-85-5 |
C52H82N20O15S4 |
|
ALPHA-甲基5-吲哚甲胺 |
α-(5-indolyl)ethylamine |
147591-52-4 |
C10H12N2 |
|
ALPHA-波菜甾醇葡糖苷 |
alpha-Spinasterol glucoside |
1745-36-4 |
C35H58O6 |
|
ALPHA-D-阿拉伯吡喃糖基叠氮化物 |
α-D-Arabinopyranosyl azide |
138892-04-3 |
C5H9N3O4 |
|
ALPHA-D-赤式戊呋喃糖-2-酮 1,3,5-三苯甲酸酯 |
1,3,5-tri-O-benzoyl-2-oxo-α-D-erythro-pentofuranose |
157037-56-4 |
C26H20O8 |
|
ALPHA-(2-氨基乙基)-OMEGA-(2-羧基乙氧基)聚氧乙烯 |
3-(2-(2-aminoethoxy)ethoxy)propanoic acid |
196936-04-6 |
C7H15NO4 |
|
ALPHA-(1-羟基环己基-3,3,4,4,5,5-D6)-4-甲氧基苯乙腈 |
1-(2-Cyano-1-(4-methoxyphenyl)ethyl)cyclohexanol-d6 |
1020719-31-6 |
C15H19NO2 |
|
ALPHA,ALPHA'双(二叔丁基膦)邻二甲苯 |
1,2-bis[di(t-butyl)phosphinomethyl]benzene |
121954-50-5 |
C24H44P2 |
|
ALPHA,3-二甲基-5-异唑乙胺 |
1-(3-Methylisoxazol-5-yl)propan-2-amine |
1207176-27-9 |
C7H12N2O |
|
ALK4/ALK5抑制剂 |
vactosertib |
1352608-82-2 |
C22H18FN7 |
|
AKT1/AKT2变构抑制剂(BAY1125976) |
BAY-1125976 |
1402608-02-9 |
C23H21N5O |
|
AGN 192403盐酸盐 |
(1S,2S,3S,4R)-3-isopropylbicyclo[2.2.1]heptan-2-amine hydrochloride |
1021868-90-5 |
C10H19N*ClH |
|
AG221甲磺酸盐 |
2-methyl-1-[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl)amino]propan-2-ol methanesulfonate |
1650550-25-6 |
CH4O3S*C19H17F6N7O |
|
AG221中间体C |
4-chloro-6-(6-(trifluoromethyl)pyridin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1,3,5-triazin-2-amine |
1446507-68-1 |
C15H7ClF6N6 |
|
AF-219或MK-7264 |
gefapixant |
1015787-98-0 |
C14H19N5O4S |
|
AE 活性硫酯 |
diethylthiophosphoryl-(Z)-(2-aminothiazol-4-yl)methoxyimino acetate |
162208-27-7 |
C10H16N3O5PS2 |
|
ACT 132577; N-[5-(4-溴苯基)-6-[2-[(5-溴-2-嘧啶基)氧基]乙氧基]-4-嘧啶基]氨基磺酰胺 |
aprocitentan |
1103522-45-7 |
C16H14Br2N6O4S |
|
ACROS网站上无此产品了 |
tert-butyl (3R)-3-amino-4-phenylbutanoate |
166023-31-0 |
C14H21NO2 |
|
AC-N'-三苯甲基-L-谷氨酰胺 |
AC-Gln(trt)-OH |
163277-79-0 |
C26H26N2O4 |
|
AC-5-ME-2'-脱氧尿苷亚磷酰胺单体 |
5-methyl dC amidite |
105931-57-5 |
C47H54N5O8P |
|
ABT-530中间体 |
(1S,4S)-1,4-bis(4-chloro-2-fluoro-5-nitrophenyl)butane-1,4-diol |
1292836-20-4 |
C16H12Cl2F2N2O6 |
|
ABT-348临床二期 |
ABT-348 |
1227939-82-3 |
C25H21FN6O2S |
|
ABT-046; 反式-4-[4-(7-氨基吡唑并[1,5-a]嘧啶-6-基)苯基]环己烷乙酸 |
2-(trans-4-(4-(7-Aminopyrazolo[1,5-a]pyrimidin-6-yl)phenyl)cyclohexyl)acetic acid |
1031336-60-3 |
C20H22N4O2 |
|
AB-005氮杂环庚烷异构体 |
(1-(1-Methylazepan-3-yl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone |
1445751-74-5 |
C23H32N2O |
|
A2A受体选择性拮抗剂,DMPX |
3,7-dimethyl-1-propargylxanthine |
14114-46-6 |
C10H10N4O2 |
|
A-羟基-3,4-二氟苯乙胺 |
2-amino-1-(3,4-difluoro-phenyl)-ethanol |
10145-04-7 |
C8H9F2NO |
|
A-甲基苯乙烯-D10 |
α-methylstyrene-d10 |
10362-82-0 |
C9H10 |
|
A-甲基-2-吡啶丙酸 |
2-methyl-3-(pyridin-2-yl)propanoic acid |
1017183-06-0 |
C9H11NO2 |
|
A-乙酰基-1,3-二氢-1,3-二氧代-2H-异吲哚-2-丙酸乙酯 |
ethyl α-(phenylimidomethyl)acetoacetate |
16880-35-6 |
C15H15NO5 |
|
A-乙基-A-甲基-1-金刚烷甲醇 |
2-(1-adamantyl)butan-2-ol |
114310-72-4 |
C14H24O |
|
A-(氨基甲基)-4-氯苯乙酸HCL |
3-Amino-2-<4-chlor-phenyl>-propionsaeure |
15032-54-9 |
C9H10ClNO2 |
|